How effective is Simponi for Ulcerative Colitis? (a real world drug study)
Summary:
Overall ratings: 3.1/5 Long term ratings: 2.3/5
This is a phase IV clinical study of how effective Simponi (golimumab) is for Ulcerative colitis and for what kind of people. The study is created by eHealthMe from 14 Simponi users and is updated continuously.
What is Simponi?
Simponi has active ingredients of golimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 86,328 Simponi users. Check the latest studies of Simponi.
What is Ulcerative colitis?
Ulcerative colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine) is found to be associated with 1,195 drugs and 2,055 conditions by eHealthMe. Check the latest studies of Ulcerative colitis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
14 people are studied for taking Simponi in Ulcerative colitis
Overall effectiveness (number of people):

Long term (1+ years) effectiveness (number of people):

Simponi effectiveness for Ulcerative colitis (number of people):
Overall:
- not at all: 0
- somewhat: 5
- moderate: 4
- high: 3
- very high: 2
Long Term:
- not at all: 0
- somewhat: 4
- moderate: 2
- high: 0
- very high: 0
Gender of people who take Simponi for Ulcerative colitis *:
- female: 85.71 %
- male: 14.29 %
Age of people who take Simponi for Ulcerative colitis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 7.14 %
- 30-39: 42.86 %
- 40-49: 28.57 %
- 50-59: 21.43 %
- 60+: 0.0 %
Who find Simponi more effective for Ulcerative Colitis?
Gender of people who take Simponi for Ulcerative colitis *:
- female: 100 %
- male: 0.0 %
Age of people who take Simponi for Ulcerative colitis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 20 %
- 30-39: 60 %
- 40-49: 0.0 %
- 50-59: 20 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Simponi?
- You can start a phase IV clinical trial to monitor Simponi safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Simponi (86,328 reports)
Treatments, associated drugs and conditions:
- Ulcerative colitis (188,235 reports)
How the study uses the data?
The study is based on golimumab (the active ingredients of Simponi) and Simponi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zenpep cause Weakness? - 3 seconds ago
- Tolterodine and Simvastatin drug interactions for men aged 50-59 - 7 seconds ago
- Could Astelin cause Weakness? - 8 seconds ago
- Could Tacrolimus cause Respiratory Alkalosis? - 9 seconds ago
- How effective is Methimazole for Hyperthyroidism? - 10 seconds ago
- Could Lamictal cause Loss Of Libido? - 10 seconds ago
- Temazepam and Aubagio drug interactions for women aged 60+ - 12 seconds ago
- Tolterodine and Simvastatin drug interactions for women aged 50-59 - 13 seconds ago
- Temazepam and Aubagio drug interactions for women aged 50-59 - 15 seconds ago
- Hallucinations and drugs of ingredients of propofol - 18 seconds ago